Charles River Laboratories

OverviewSuggest Edit

Charles River Laboratories International is a full-service, early-stage contract research organization (CRO). It operates through 3 segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment offers research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services, as well as controlled, consistent, customized primary cells and blood components derived from normal and mobilized peripheral blood, bone marrow, and cord blood. The DSA segment provides regulated and non-regulated DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. The Manufacturing segment performs specialized testing of biologics, supplies fertile chicken eggs and chickens, and delivers in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceutical and consumer products.

TypePublic
Founded1947
HQWilmington, MA, US
Websitecriver.com
Employee Ratings3.4
Overall CultureC

Latest Updates

Employees (est.) (Dec 2021)18,600(+2%)
Job Openings1,149
Revenue (FY, 2021)$3.5 B(+22%)
Share Price (May 2022)$230.2(+4%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Charles River Laboratories

James C. Foster

James C. Foster

Chairman, President & Chief Executive Officer
William D. Barbo

William D. Barbo

Corporate Executive Vice President & Chief Commercial Officer
Joseph W. LaPlume

Joseph W. LaPlume

Corporate Executive Vice President, Corporate Development & Strategy
Flavia Pease

Flavia Pease

Corporate Executive Vice President & Chief Financial Officer
Victoria Creamer

Victoria Creamer

Corporate Executive Vice President, Chief People Officer
Kerstin Dolph

Kerstin Dolph

Corporate Senior Vice President, Biologics Solutions
Show more

Charles River Laboratories Office Locations

Charles River Laboratories has offices in Wilmington, Ashland, Charleston, Chicago and in 89 other locations
Wilmington, MA, US (HQ)
251 Ballardvale St
Ashland, OH, US
1407 George Rd
Charleston, SC, US
1023 Wappoo Rd #43B
Chicago, IL, US
Iit Tower, 10 W 35th St 8th Floor
Durham, NC, US
4025 Stirrup Creek Dr #150
Frederick, MD, US
8501 Progress Drive
Show all (93)

Charles River Laboratories Financials and Metrics

Charles River Laboratories Revenue

Embed Graph
View revenue for all periods
Charles River Laboratories's revenue was reported to be $3.54 b in FY, 2021
USD

Revenue (FY, 2021)

3.5b

Gross profit (FY, 2021)

1.3b

Gross profit margin (FY, 2021), %

37.7%

Net income (FY, 2021)

398.8m

EBIT (FY, 2021)

589.9m

Market capitalization (26-May-2022)

11.7b

Closing stock price (26-May-2022)

230.2

Cash (25-Dec-2021)

241.2m

EV

14.4b
Charles River Laboratories's current market capitalization is $11.7 b.
Annual
USDFY, 2019FY, 2020FY, 2021

Revenue

2.6b2.9b3.5b

Revenue growth, %

16%12%

Cost of goods sold

1.7b1.9b2.2b

Gross profit

958.3m1.1b1.3b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

604.6m657.6m668.0m707.1m682.6m743.3m824.6m914.6m895.9m

Cost of goods sold

392.8m419.5m421.8m455.0m450.3m454.0m516.3m572.6m558.7m

Gross profit

211.8m238.1m246.1m252.1m232.2m289.3m308.3m342.0m337.2m

Gross profit Margin, %

35%36%37%36%34%39%37%37%38%
Annual
USDFY, 2019FY, 2020FY, 2021

Cash

238.0m228.4m241.2m

Accounts Receivable

514.0m617.7m642.9m

Prepaid Expenses

52.6m96.7m93.5m

Inventories

160.7m185.7m199.1m
Annual
USDFY, 2019FY, 2020FY, 2021

Net Income

254.1m365.3m398.8m

Depreciation and Amortization

198.1m234.9m265.5m

Inventories

(21.4m)(18.4m)(25.2m)

Accounts Payable

29.8m748.0k44.9m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Net Income

55.7m100.0m173.5m50.8m118.5m221.1m63.9m153.9m259.0m

Depreciation and Amortization

45.4m94.5m146.3m57.3m114.5m174.0m61.5m129.6m198.3m

Inventories

(2.5m)(2.6m)(13.0m)4.1m(1.9m)(14.1m)(11.4m)(7.1m)(5.6m)

Accounts Payable

10.2m18.2m24.5m(10.0m)(25.6m)(12.3m)9.6m(13.4m)11.4m
USDQ1, 2019

Debt/Equity

1.2 x

Debt/Assets

0.4 x

Financial Leverage

2.8 x
Show all financial metrics

Charles River Laboratories Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020FY, 2021

Backlog (RMS)

$96.8 m$106.5 m$128.7 m$167.6 m$266 m

Countries

2320202020

Facilities

808090100110

Strains

150150150150160

Charles River Laboratories Acquisitions / Subsidiaries

Company NameDateDeal Size
Vigene Biosciences, Inc.June 29, 2021$292.5 m
Retrogenix LimitedMarch 31, 2021$83 m
Cognate BioServicesMarch 29, 2021$875 m
HemaCareDecember 16, 2019
CiToxLABFebruary 13, 2019$448 m
MPI ResearchFebruary 13, 2018$800 m
KWS BioTestJanuary 11, 2018
Brains On-LineAugust 07, 2017$21 m
Agilux LaboratoriesSeptember 28, 2016$64 m
Blue Stream LaboratoriesJune 27, 2016
Show more

Charles River Laboratories Revenue Breakdown

Embed Graph

Charles River Laboratories revenue breakdown by business segment: 19.5% from RMS, 59.5% from DSA and 21.0% from Manufacturing

Charles River Laboratories revenue breakdown by geographic segment: 54.6% from US, 29.3% from Europe, 6.3% from Asia Pacific, 9.6% from Canada and 0.2% from Other

Human Capital Metrics

Embed Graph

Charles River Laboratories Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Charles River Laboratories Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Charles River Laboratories Online and Social Media Presence

Embed Graph

Charles River Laboratories Company Culture

  • Overall Culture

    C

    66/100

  • CEO Rating

    C

    65/100

  • Compensation

    B

    69/100

Learn more on Comparably

Charles River Laboratories News and Updates

Global Protein Sequencing Market Report 2022: Company Profiles of Global Players, including Charles River Laboratories, Selvita, Shimadzu, Thermo Fisher Scientific and Agilent

Dublin, March 07, 2022 (GLOBE NEWSWIRE) -- The "Protein Sequencing: Global Market" report has been added to ResearchAndMarkets.com's offering.

Valo Health Is Partnering With Charles River Laboratories To Accelerate Preclinical Drug Discovery

The two companies will begin offering its combined platform product in mid-2022.

USD 4.63 bn growth in Regulatory Affairs Outsourcing Market from 2021 to 2026 | Evolving Opportunities with Certara Inc., Charles River Laboratories International Inc. & Genpact Ltd | 17000+ Technavio Reports

NEW YORK, Dec. 17, 2021 /PRNewswire/ -- The regulatory affairs outsourcing market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Certara Inc., Charles River Laboratories International Inc., Genpact Ltd., Icon Plc, Laboratory Corp. of America...

Worldwide Clinical Laboratory Services Industry to 2026 - Players Include Charles River Laboratories, Illumina and Siemens Healthcare Among Others

Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "Clinical Laboratory Services Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global clinical laboratory services market exhibited moderate growth …

Charles River Laboratories Reinforces Commitment to South Carolina

Operations maintain the state’s leadership in the global biopharmaceutical industry Operations maintain the state’s leadership in the global biopharmaceutical industry

USD 360 Mn growth in Pharmacokinetics Services Market from 2020 to 2025 | Certara Inc., Charles River Laboratories International Inc., and Eurofins Scientific SE emerge as key players | Technavio

NEW YORK, Oct. 29, 2021 /PRNewswire/ -- Technavio's latest research report on the Pharmacokinetics Services Market offers a comprehensive analysis on new product launches, the latest trends, and the post-pandemic impact on businesses. The pharmacokinetics services market value is...
Show more

Charles River Laboratories Blogs

Digital Pathology

Digital Pathology arossi Fri, 04/10/2020 - 13:23 Digital Primary and Peer Review Comprehensive digital pathology has arrived at Charles River to accelerate discovery and safety programs around the globe. The average toxicology program involves the assess…

Tracking SARS-COV2 from Europe (Abstract Science, April 5 – 11)

Also: researching spike proteins and the antibiotic properties of silver The post Tracking SARS-COV2 from Europe (Abstract Science, April 5 – 11) appeared first on eureka.

Let‘s Keep on Track for Our Best Future

Given my family history of diabetes, stress-eating is not an option, even during a pandemic The post Let‘s Keep on Track for Our Best Future appeared first on eureka.

Shipping Logistics: Design and Management

Shipping Logistics: Design and Management arossi Wed, 04/08/2020 - 16:09 Global Distribution, Logistics and Cold Chain Management You’re ready to initiate testing on your new compound(s) or study material of interest, but how are you going to get your ma…

Tissue Image Analysis in Regulatory Environment

Are image analysis algorithms for digital pathology compliant with regulatory requirements? The post Tissue Image Analysis in Regulatory Environment appeared first on eureka.

Supporting COVID-19 Vaccine Developers with Rapid Sterility Release Testing

Supporting COVID-19 Vaccine Developers with Rapid Sterility Release Testing cnucci Wed, 04/08/2020 - 13:20 Rapid Vaccine Production Requires Rapid Sterility Testing To answer this need, Charles River Microbial Solutions has developed a complete rapid mic…
Show more

Charles River Laboratories Frequently Asked Questions

  • When was Charles River Laboratories founded?

    Charles River Laboratories was founded in 1947.

  • Who are Charles River Laboratories key executives?

    Charles River Laboratories's key executives are James C. Foster, William D. Barbo and Joseph W. LaPlume.

  • How many employees does Charles River Laboratories have?

    Charles River Laboratories has 18,600 employees.

  • What is Charles River Laboratories revenue?

    Latest Charles River Laboratories annual revenue is $3.5 b.

  • What is Charles River Laboratories revenue per employee?

    Latest Charles River Laboratories revenue per employee is $190.3 k.

  • Who are Charles River Laboratories competitors?

    Competitors of Charles River Laboratories include SNBL, Eurofins and ICON.

  • Where is Charles River Laboratories headquarters?

    Charles River Laboratories headquarters is located at 251 Ballardvale St, Wilmington.

  • Where are Charles River Laboratories offices?

    Charles River Laboratories has offices in Wilmington, Ashland, Charleston, Chicago and in 89 other locations.

  • How many offices does Charles River Laboratories have?

    Charles River Laboratories has 93 offices.